DBD Statistics
Total Valuation
Binh Dinh Pharmaceutical and Medical Equipment JSC has a market cap or net worth of VND 4.43 trillion. The enterprise value is 4.08 trillion.
Market Cap | 4.43T |
Enterprise Value | 4.08T |
Important Dates
The last earnings date was Friday, October 25, 2024.
Earnings Date | Oct 25, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Binh Dinh Pharmaceutical and Medical Equipment JSC has 93.55 million shares outstanding. The number of shares has decreased by -0.00% in one year.
Current Share Class | n/a |
Shares Outstanding | 93.55M |
Shares Change (YoY) | -0.00% |
Shares Change (QoQ) | -0.00% |
Owned by Insiders (%) | 3.13% |
Owned by Institutions (%) | 20.63% |
Float | 90.62M |
Valuation Ratios
The trailing PE ratio is 18.76 and the forward PE ratio is 16.34.
PE Ratio | 18.76 |
Forward PE | 16.34 |
PS Ratio | 2.61 |
PB Ratio | 2.70 |
P/TBV Ratio | n/a |
P/FCF Ratio | 25.58 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.03, with an EV/FCF ratio of 23.59.
EV / Earnings | 17.31 |
EV / Sales | 2.41 |
EV / EBITDA | 11.03 |
EV / EBIT | 12.49 |
EV / FCF | 23.59 |
Financial Position
The company has a current ratio of 3.72, with a Debt / Equity ratio of 0.03.
Current Ratio | 3.72 |
Quick Ratio | 2.15 |
Debt / Equity | 0.03 |
Debt / EBITDA | 0.14 |
Debt / FCF | 0.28 |
Interest Coverage | 69.59 |
Financial Efficiency
Return on equity (ROE) is 17.94% and return on invested capital (ROIC) is 11.94%.
Return on Equity (ROE) | 17.94% |
Return on Assets (ROA) | 9.39% |
Return on Capital (ROIC) | 11.94% |
Revenue Per Employee | 1.26B |
Profits Per Employee | 175.59M |
Employee Count | 1,303 |
Asset Turnover | 0.84 |
Inventory Turnover | 1.76 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.83% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +2.83% |
50-Day Moving Average | 46,921.00 |
200-Day Moving Average | 43,600.90 |
Relative Strength Index (RSI) | 44.61 |
Average Volume (20 Days) | 217,000 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Binh Dinh Pharmaceutical and Medical Equipment JSC had revenue of VND 1.69 trillion and earned 235.82 billion in profits. Earnings per share was 2,520.67.
Revenue | 1.69T |
Gross Profit | 818.36B |
Operating Income | 301.84B |
Pretax Income | 321.88B |
Net Income | 235.82B |
EBITDA | 345.30B |
EBIT | 301.84B |
Earnings Per Share (EPS) | 2,520.67 |
Balance Sheet
The company has 392.13 billion in cash and 48.00 billion in debt, giving a net cash position of 344.13 billion or 3,678.46 per share.
Cash & Cash Equivalents | 392.13B |
Total Debt | 48.00B |
Net Cash | 344.13B |
Net Cash Per Share | 3,678.46 |
Equity (Book Value) | 1.64T |
Book Value Per Share | 17,497.84 |
Working Capital | 1.01T |
Cash Flow
In the last 12 months, operating cash flow was 337.71 billion and capital expenditures -164.75 billion, giving a free cash flow of 172.96 billion.
Operating Cash Flow | 337.71B |
Capital Expenditures | -164.75B |
Free Cash Flow | 172.96B |
FCF Per Share | 1,848.77 |
Margins
Gross margin is 48.31%, with operating and profit margins of 17.82% and 16.14%.
Gross Margin | 48.31% |
Operating Margin | 17.82% |
Pretax Margin | 19.00% |
Profit Margin | 16.14% |
EBITDA Margin | 20.38% |
EBIT Margin | 17.82% |
FCF Margin | 10.21% |
Dividends & Yields
Binh Dinh Pharmaceutical and Medical Equipment JSC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 0.03% |
Buyback Yield | 0.00% |
Shareholder Yield | 0.00% |
Earnings Yield | 5.33% |
FCF Yield | 3.91% |
Stock Splits
The last stock split was on June 19, 2024. It was a forward split with a ratio of 1.25.
Last Split Date | Jun 19, 2024 |
Split Type | Forward |
Split Ratio | 1.25 |
Scores
Binh Dinh Pharmaceutical and Medical Equipment JSC has an Altman Z-Score of 7.17.
Altman Z-Score | 7.17 |
Piotroski F-Score | n/a |